ARCHIVES

Choice Of Reconstruction Can Depend On Who Consults

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

Program Announcement Completes NCI switch To Control Research

April 16, 1982

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution

July 16, 1982